169 related articles for article (PubMed ID: 17388662)
1. HIV patients developing primary CNS lymphoma lack EBV-specific CD4+ T cell function irrespective of absolute CD4+ T cell counts.
Gasser O; Bihl FK; Wolbers M; Loggi E; Steffen I; Hirsch HH; Günthard HF; Walker BD; Brander C; Battegay M; Hess C;
PLoS Med; 2007 Mar; 4(3):e96. PubMed ID: 17388662
[TBL] [Abstract][Full Text] [Related]
2. Do CD4+ T cell functional responses to Epstein-Barr virus provide protective immunity against CNS lymphoma in AIDS?
Jacobson MA
PLoS Med; 2007 Mar; 4(3):e110. PubMed ID: 17388670
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for pediatric human immunodeficiency virus-related malignancy.
Pollock BH; Jenson HB; Leach CT; McClain KL; Hutchison RE; Garzarella L; Joshi VV; Parmley RT; Murphy SB
JAMA; 2003 May; 289(18):2393-9. PubMed ID: 12746363
[TBL] [Abstract][Full Text] [Related]
4. Lymphoma and Epstein-Barr virus DNA in blood during interleukin-2 therapy in antiretroviral-naïve HIV-1-infected patients: a substudy of the ANRS 119 trial.
de Lastours V; LeGoff J; Brière J; Agbalika F; Boulet T; Lévy Y; Simon F; Aboulker JP; Molina JM
HIV Med; 2014 Jan; 15(1):23-9. PubMed ID: 24007426
[TBL] [Abstract][Full Text] [Related]
5. Novel method for detection of virus-specific CD41+ T cells indicates a decreased EBV-specific CD4+ T cell response in untreated HIV-infected subjects.
Piriou ER; van Dort K; Nanlohy NM; van Oers MH; Miedema F; van Baarle D
Eur J Immunol; 2005 Mar; 35(3):796-805. PubMed ID: 15724243
[TBL] [Abstract][Full Text] [Related]
6. Significance of Epstein-Barr virus (HHV-4) and CMV (HHV-5) infection among subtype-C human immunodeficiency virus-infected individuals.
Sachithanandham J; Kannangai R; Pulimood SA; Desai A; Abraham AM; Abraham OC; Ravi V; Samuel P; Sridharan G
Indian J Med Microbiol; 2014; 32(3):261-9. PubMed ID: 25008818
[TBL] [Abstract][Full Text] [Related]
7. Circulating Epstein-Barr virus (EBV) in HIV-infected patients and its relation with primary brain lymphoma.
Fellner MD; Durand K; Correa RM; Redini L; Yampolsky C; Colobraro A; Sevlever G; Teyssié AR; Benetucci J; Picconi MA
Int J Infect Dis; 2007 Mar; 11(2):172-8. PubMed ID: 16931088
[TBL] [Abstract][Full Text] [Related]
8. Assessment of immunovirological features in HIV related non-Hodgkin lymphoma patients and their impact on outcome.
Tedeschi R; Bortolin MT; Bidoli E; Zanussi S; Pratesi C; Vaccher E; Tirelli U; De Paoli P
J Clin Virol; 2012 Apr; 53(4):297-301. PubMed ID: 22244256
[TBL] [Abstract][Full Text] [Related]
9. CD4-Positive T-Cell Primary Central Nervous System Lymphoma in an HIV Positive Patient.
Nael A; Walavalkar V; Wu W; Nael K; Kim R; Rezk S; Zhao X
Am J Clin Pathol; 2016 Feb; 145(2):258-65. PubMed ID: 27124906
[TBL] [Abstract][Full Text] [Related]
10. Plasma Epstein-Barr viral load measurement as a diagnostic marker of lymphoma in HIV-infected patients.
Navarro JT; Hernández A; Rodríguez-Manzano J; Mate JL; Grau J; Morgades M; Martró E; Tural C; Ribera JM; Matas L
Med Clin (Barc); 2010 Oct; 135(11):485-90. PubMed ID: 20673682
[TBL] [Abstract][Full Text] [Related]
11. Ganciclovir is associated with low or undetectable Epstein-Barr virus DNA load in cerebrospinal fluid of patients with HIV-related primary central nervous system lymphoma.
Bossolasco S; Falk KI; Ponzoni M; Ceserani N; Crippa F; Lazzarin A; Linde A; Cinque P
Clin Infect Dis; 2006 Feb; 42(4):e21-5. PubMed ID: 16421782
[TBL] [Abstract][Full Text] [Related]
12. Detection of opportunistic DNA viral infections by multiplex PCR among HIV infected individuals receiving care at a tertiary care hospital in South India.
Sachithanandham J; Ramamurthy M; Kannangai R; Daniel HD; Abraham OC; Rupali P; Pulimood SA; Abraham AM; Sridharan G
Indian J Med Microbiol; 2009; 27(3):210-6. PubMed ID: 19584500
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus-associated peripheral T-cell and NK-cell proliferative disease/lymphoma: clinicopathologic, serologic, and molecular analysis.
Mitarnun W; Suwiwat S; Pradutkanchana J; Saechan V; Ishida T; Takao S; Mori A
Am J Hematol; 2002 May; 70(1):31-8. PubMed ID: 11994979
[TBL] [Abstract][Full Text] [Related]
14. Blood Epstein-Barr virus DNA load and risk of progression to AIDS-related systemic B lymphoma.
Leruez-Ville M; Seng R; Morand P; Boufassa F; Boue F; Deveau C; Rouzioux C; Goujard C; Seigneurin JM; Meyer L
HIV Med; 2012 Sep; 13(8):479-87. PubMed ID: 22414000
[TBL] [Abstract][Full Text] [Related]
15. Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy.
Henrich TJ; Hobbs KS; Hanhauser E; Scully E; Hogan LE; Robles YP; Leadabrand KS; Marty FM; Palmer CD; Jost S; Körner C; Li JZ; Gandhi RT; Hamdan A; Abramson J; LaCasce AS; Kuritzkes DR
J Infect Dis; 2017 Jul; 216(2):254-262. PubMed ID: 28838149
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus (EBV)-associated primary central nervous system lymphoma: is incidence of EBV expression associated with median survival time?
Utsuki S; Oka H; Miyajima Y; Kijima C; Yasui Y; Fujii K
Brain Tumor Pathol; 2011 Apr; 28(2):145-9. PubMed ID: 21327439
[TBL] [Abstract][Full Text] [Related]
17. EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity.
Gandhi MK; Hoang T; Law SC; Brosda S; O'Rourke K; Tobin JWD; Vari F; Murigneux V; Fink L; Gunawardana J; Gould C; Oey H; Bednarska K; Delecluse S; Trappe RU; Merida de Long L; Sabdia MB; Bhagat G; Hapgood G; Blyth E; Clancy L; Wight J; Hawkes E; Rimsza LM; Maguire A; Bojarczuk K; Chapuy B; Keane C
Blood; 2021 Mar; 137(11):1468-1477. PubMed ID: 33202420
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus DNA loads in adult human immunodeficiency virus type 1-infected patients receiving highly active antiretroviral therapy.
Ling PD; Vilchez RA; Keitel WA; Poston DG; Peng RS; White ZS; Visnegarwala F; Lewis DE; Butel JS
Clin Infect Dis; 2003 Nov; 37(9):1244-9. PubMed ID: 14557970
[TBL] [Abstract][Full Text] [Related]
19. Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy.
Keane NM; Price P; Lee S; Almeida CA; Stone SF; James I; French MA
HIV Med; 2004 Nov; 5(6):407-14. PubMed ID: 15544692
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
